News
ITT
130.40
+0.66%
0.86
Honeywell (HON) to Report Q1 Earnings: Is a Beat in Store?
NASDAQ · 2d ago
Weekly Report: what happened at ITT last week (0415-0419)?
Weekly Report · 2d ago
Merck garners Canadian approval for Keytruda in first-line gastroesophageal cancer
Seeking Alpha · 5d ago
GE Aerospace (GE) Gears Up for Q1 Earnings: What to Expect
NASDAQ · 6d ago
Beyond The Numbers: 4 Analysts Discuss ITT Stock
ITT Inc is a diversified manufacturer of engineered critical components for the transportation, industrial and energy markets. The company has an average 12-month price target of $153.0. Four analysts have provided ratings for ITT in the past three months. ITT has a positive revenue growth rate of 7.04%. The company faces challenges in its financial performance.
Benzinga · 04/17 15:00
ITT Inc Is Maintained at Buy by Stifel
Dow Jones · 04/17 14:58
ITT Inc Price Target Raised to $150.00/Share From $141.00 by Stifel
Dow Jones · 04/17 14:58
Stifel Maintains Buy on ITT, Raises Price Target to $150
Benzinga · 04/17 14:47
Here's Why You Should Retain Honeywell (HON) in Your Portfolio
NASDAQ · 04/17 14:36
U.S. RESEARCH ROUNDUP-3M, J&J, Nuvalent
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. 3M, J&J and Nuvalent are among the companies. Analysts also raise their targets on Amazon, Tractor Supply, UnitedHealth Group and Amgen. NEW: 3M cuts its target price to $110 from $118; 10X Genomics cuts target price.
Reuters · 04/17 07:48
ITT INC <ITT.N>: STIFEL RAISES TARGET PRICE TO $150 FROM $141
Reuters · 04/17 04:41
3 Reasons Why Growth Investors Shouldn't Overlook ITT (ITT)
NASDAQ · 04/16 16:45
ITT Announces Participation in Oppenheimer’s 19th Annual Industrial Growth Conference
ITT will participate in Oppenheimer’s 19th Annual Industrial Growth Conference on Tuesday, May 7. Chief Financial Officer Emmanuel Caprais will present virtually from 11:15 to 11:50 a.m. ET. A live audio webcast of the presentation will be available online. ITT is a leading manufacturer of critical components.
Barchart · 04/16 05:30
Viracta Therapeutics reports positive results from stage 1 of phase 2 trial for lymphoma treatment
Viracta Therapeutics reports positive results from stage 1 of phase 2 trial for lymphoma treatment. The company has a positive topline results from Stage 1 of the Phase 2 NAVAL-1 trial for T-cell lymphoma. Patients in the Nana-val treatment arm achieved clinically meaningful responses with an overall response rate of 50%.
Seeking Alpha · 04/15 12:40
Weekly Report: what happened at ITT last week (0408-0412)?
Weekly Report · 04/15 09:07
With EPS Growth And More, ITT (NYSE:ITT) Makes An Interesting Case
ITT has grown its earnings per share by 13% over the last three years. The company is growing its revenue by 9.9% to US$3.3b. ITT's CEO pay is reasonable for a company of its size. Insiders hold US$46m worth of shares in ITT. With a reasonable level of insider ownership, ITT is a company worth watching.
Simply Wall St · 04/11 11:08
Press Release: ITT to Release First Quarter 2024 Results on Thursday, May 2
ITT to Release First Quarter 2024 Results on Thursday, May 2. The company will hold a conference call at 8:30 a.m. ET on May 2 to discuss its first quarter performance. ITT is a diversified leading manufacturer of critical components and customized technology solutions.
Dow Jones · 04/11 10:30
ITT Inc Is Maintained at Overweight by Keybanc
Dow Jones · 04/11 08:58
ITT Inc Price Target Raised to $150.00/Share From $136.00 by Keybanc
Dow Jones · 04/11 08:58
Keybanc Maintains Overweight on ITT, Raises Price Target to $150
Benzinga · 04/11 08:48
More
Webull provides a variety of real-time ITT stock news. You can receive the latest news about Itt Inc through multiple platforms. This information may help you make smarter investment decisions.
About ITT
ITT Inc. is a diversified manufacturer of engineered critical components and customized technology solutions for the transportation, industrial and energy markets. Its segments include Motion Technologies (MT), Industrial Process (IP), and Connect & Control Technologies (CCT). The MT segment manufactures brake components and specialized sealing solutions, shock absorbers and damping technologies primarily for the global automotive, truck and trailer, public bus and rail transportation markets. The IP segment manufactures engineered fluid process equipment serving a diversified mix of customers in global industries such as chemical, energy, mining, and other industrial process markets and is a provider of plant optimization and efficiency solutions and aftermarket services and parts. The CCT segment manufactures connector solutions, critical energy absorption, flow control components, and composite materials for the aerospace and defense, general industrial, medical, and energy markets.